Combining Immunotherapy and Anti-angiogenesis Remodeling the Immune-microenvironment of LKB1/KEAP1-mutant Non-small Cell Lung Cancer
07:30am - 03:35pm EST - April 5, 2024



Author(s):
  • Keyi Jia, MD, Tongji University Affiliated Shanghai Pulmonary Hospital

Tags: Pre-Clinical Oncology

Display Label Action